Xenografts
Findings from R. Krumbach and Co-Researchers Advance Knowledge in Xenografts
Published in Gene Therapy Weekly, July 7th, 2011
2011 JUL 7 -- Research findings, "Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance," are discussed in a new report. According to the authors of a study from Freiburg, Germany, "Cetuximab (Erbitux®) targets the epidermal growth factor receptor (EGFR) and is approved for treatment of colorectal and head and neck cancer. Despite wide expression of EGFR, only a subgroup of cancer patients responds to cetuximab therapy."
"In the present study we assessed the cetuximab response in vivo of 79 human patient-derived xenografts originating from five tumor histotypes. We...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-07-07)
More Articles from Gene Therapy Weekly
- Epithelial Cells
Findings in Epithelial Cells Reported from S.J. Soenen and Co-Researchers - Dyskinesia
New Findings from University of Lund Describe Advances in Dyskinesia - Leukemia
New Findings from X.F. Niu and Co-Researchers in the Area of Leukemia Described - Glycoside Hydrolases
New Glycoside Hydrolases Findings from University of Kagoshima Described - Gene Therapy
Next generation gene therapy - Antisense Technology
Non-coding RNA has role in inherited neurological disorder -- and maybe other brain diseases too - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
